FDA INITIATES WITHDRAWAL PROCEEDINGS FOR 25 QUANTUM ANDAs; AGENCY WILL REDUCE BIOEQUIVALENCE STATUS TO "BX"; UNTRUE STATEMENTS AT ROOT OF PROBLEM

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".